Department of General Practice and Primary Health Care, School of Population Health, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
Department of General Practice and Primary Health Care, School of Population Health, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
BMJ Open. 2022 Jun 8;12(6):e060145. doi: 10.1136/bmjopen-2021-060145.
In New Zealand, significant inequities exist between Māori and Pacific peoples compared with non-Māori, non-Pacific peoples in cardiovascular disease (CVD) risk factors, hospitalisations and management rates. This review will quantify and qualify already-reported gaps in CVD risk assessment and management in primary care for Māori and Pacific peoples compared with non-Māori/non-Pacific peoples in New Zealand.
We will conduct a systematic search of the following electronic databases and websites from 1 January 2000 to 31 December 2021: MEDLINE (OVID), EMBASE, Scopus, CINAHL Plus, NZresearch.org, National Library Catalogue (Te Puna), Index New Zealand (INNZ), Australia/New Zealand Reference Centre. In addition, we will search relevant websites such as the Ministry of Health and research organisations. Data sources will include published peer reviewed articles, reports and theses employing qualitative, quantitative and mixed methods.Two reviewers will independently screen the titles and abstracts of the citations and grade each as eligible, not eligible or might be eligible. Two reviewers will read each full report, with one medically qualified reviewer reading all reports and two other reviewers reading half each. The final list of included citations will be compiled from the results of the full report reading and agreed on by three reviewers. Data abstracted will include authors, title, year, study characteristics and participant characteristics. Data analysis and interpretation will involve critical inquiry and a strength-based approach that is inclusive of Māori and Pacific values. This means that critical appraisal includes an assessment of quality from an Indigenous perspective.
Ethical approval is not required. The findings will be published in a peer-reviewed journal and shared with stakeholders. This review contributes to a larger project which creates a Quality-Improvement Equity Roadmap to reduce barriers to Māori and Pacific peoples accessing evidence-based CVD care.
在新西兰，与非毛利/非太平洋族裔相比，毛利族和太平洋族裔在心血管疾病 (CVD) 风险因素、住院率和管理率方面存在显著的不平等。本综述将定量和定性评估新西兰毛利族和太平洋族裔与非毛利/非太平洋族裔在初级保健中 CVD 风险评估和管理方面已经报告的差距。
我们将从 2000 年 1 月 1 日至 2021 年 12 月 31 日，对以下电子数据库和网站进行系统检索：MEDLINE（OVID）、EMBASE、Scopus、CINAHL Plus、NZresearch.org、国家图书馆目录 (Te Puna)、新西兰索引 (INNZ)、澳大利亚/新西兰参考中心。此外，我们还将搜索卫生部和研究组织等相关网站。数据源将包括已发表的同行评议文章、报告和论文，采用定性、定量和混合方法。两名评审员将独立筛选引用的标题和摘要，并将其分别归类为符合、不符合或可能符合条件。两名评审员将阅读每份完整报告，其中一名具有医学资格的评审员阅读所有报告，另外两名评审员阅读一半报告。从完整报告阅读的结果中编制包括引文的最终列表，并由三名评审员共同商定。提取的数据将包括作者、标题、年份、研究特征和参与者特征。数据分析和解释将涉及批判性探究和以包容性的毛利和太平洋价值观为基础的优势方法。这意味着批判性评价包括从本土视角评估质量。
不需要伦理批准。研究结果将发表在同行评议的期刊上，并与利益相关者共享。本综述是一个更大项目的一部分，该项目创建了一个质量改进公平路线图，以减少毛利族和太平洋族裔获得循证 CVD 护理的障碍。
